Evidence map›Paper›PMID 36559082›Full record

ReviewPharmaceutics2022

The Application and Challenge of Binder Jet 3D Printing Technology in Pharmaceutical Manufacturing.

Xuejun Chen, Shanshan Wang, Jie Wu, Shuwei Duan, Xiaolong Wang, Xiaoxuan Hong, Xiaolu Han, Conghui Li, Dongzhou Kang, Zengming Wang and 1 more

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Additive manufacturing in nano drug delivery systems.Pharmaceutical science advances · 2024
    Review
  11. The Exploration of Ink Formulations in Binder Jet 3D Printing Drugs.3D printing and additive manufacturing · 2024
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Xuejun ChenPharmaceutical Experiment Center, College of Pharmacy, Yanbian University, Yanji 133002, China.
Shanshan WangCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin 300457, China.
Jie WuDepartment of Nephrology, First Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Kidney Diseases, Beijing 100853, China.
Shuwei DuanDepartment of Nephrology, First Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Kidney Diseases, Beijing 100853, China.
Xiaolong WangDepartment of Nephrology, First Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Kidney Diseases, Beijing 100853, China.
Xiaoxuan HongState Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Xiaolu HanState Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Conghui LiState Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Dongzhou KangPharmaceutical Experiment Center, College of Pharmacy, Yanbian University, Yanji 133002, China.
Zengming WangState Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Aiping ZhengState Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Chinese PLA General Hospital · CNYanbian University · CNTianjin University of Science and Technology · CN

Funding

Beijing Natural Science Foundation of China No. L202043National Natural Science Foundation of China No. 82073793
6 · The paper itself

Abstract

Three-dimensional (3D) printing is an additive manufacturing technique that creates objects under computer control. Owing to the rapid advancement of science and technology, 3D printing technology has been widely utilized in processing and manufacturing but rarely used in the pharmaceutical field. The first commercial form of Spritam

Indexed as

binder jet 3D printingcomputer-aided designdrug delivery systemmechanismpharmaceutical manufacturing

Identifiers

PMID36559082
PMCPMC9786002
OpenAlexW4309855244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.